Advertisement

Index by author

September 01, 2004; Volume 32,Issue 9

A

  1. Ahlf, Susan B.

    1. KINETIC CHARACTERIZATION OF P-GLYCOPROTEIN-MEDIATED EFFLUX OF RHODAMINE 6G IN THE INTACT RABBIT LUNG
      David L. Roerig, Said H. Audi and Susan B. Ahlf
      Drug Metabolism and Disposition September 2004, 32 (9) 953-958; DOI: https://doi.org/10.1124/dmd.104.000042

  2. Ali, Rabia Y.

    1. EFFECT OF PROTOTYPICAL INDUCING AGENTS ON P-GLYCOPROTEIN AND CYP3A EXPRESSION IN MOUSE TISSUES
      Christopher J. Matheny, Rabia Y. Ali, Xiaodong Yang and Gary M. Pollack
      Drug Metabolism and Disposition September 2004, 32 (9) 1008-1014;

  3. Ali, Shazia Y.

    1. ALTERED PHARMACOKINETICS OF OMEPRAZOLE IN CYSTIC FIBROSIS KNOCKOUT MICE RELATIVE TO WILD-TYPE MICE
      Melanie N. Tallman, Shazia Y. Ali and Philip C. Smith
      Drug Metabolism and Disposition September 2004, 32 (9) 902-905;

  4. Audi, Said H.

    1. KINETIC CHARACTERIZATION OF P-GLYCOPROTEIN-MEDIATED EFFLUX OF RHODAMINE 6G IN THE INTACT RABBIT LUNG
      David L. Roerig, Said H. Audi and Susan B. Ahlf
      Drug Metabolism and Disposition September 2004, 32 (9) 953-958; DOI: https://doi.org/10.1124/dmd.104.000042

  5. Awano, Katsuya

    1. IN VITRO METABOLISM OF MK-0767 [(±)-5-[(2,4-DIOXOTHIAZOLIDIN-5-YL)METHYL]-2-METHOXY-N-[[(4-TRIFLUOROMETHYL) PHENYL]METHYL]BENZAMIDE], A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α/γ AGONIST. I. ROLE OF CYTOCHROME P450, METHYLTRANSFERASES, FLAVIN MONOOXYGENASES, AND ESTERASES
      Bindhu V. Karanam, Cornelis E.C.A. Hop, David Q. Liu, Mike Wallace, Dennis Dean, Hiroya Satoh, Masakatsu Komuro, Katsuya Awano and Stella H. Vincent
      Drug Metabolism and Disposition September 2004, 32 (9) 1015-1022; DOI: https://doi.org/10.1124/dmd.104.000034

B

  1. Baldwin, R. Michael

    1. BIOACTIVATION OF 1,1-DICHLOROETHYLENE TO ITS EPOXIDE BY CYP2E1 AND CYP2F ENZYMES
      Andrea C. Simmonds, Christopher A. Reilly, R. Michael Baldwin, Burhan I. Ghanayem, Diane L. Lanza, Garold S. Yost, Kathy S. Collins and Poh-Gek Forkert
      Drug Metabolism and Disposition September 2004, 32 (9) 1032-1039;

  2. Barbuch, Robert J.

    1. SELECTIVE REDUCTION OF N-OXIDES TO AMINES: APPLICATION TO DRUG METABOLISM
      Palaniappan Kulanthaivel, Robert J. Barbuch, Rita S. Davidson, Ping Yi, Gregory A. Rener, Edward L. Mattiuz, Chad E. Hadden, Lawrence A. Goodwin and William J. Ehlhardt
      Drug Metabolism and Disposition September 2004, 32 (9) 966-972;

  3. Bergstrand, S.

    1. PHARMACOKINETICS AND METABOLISM OF TESAGLITAZAR, A NOVEL DUAL-ACTING PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α/γ AGONIST, AFTER A SINGLE ORAL AND INTRAVENOUS DOSE IN HUMANS
      H. Ericsson, B. Hamrén, S. Bergstrand, M. Elebring, L. Fryklund, M. Heijer and K. P. Öhman
      Drug Metabolism and Disposition September 2004, 32 (9) 923-929;

  4. Bickel, Ulrich

    1. EFFECT OF POLY(ETHYLENE IMINE) MOLECULAR WEIGHT AND PEGYLATION ON ORGAN DISTRIBUTION AND PHARMACOKINETICS OF POLYPLEXES WITH OLIGODEOXYNUCLEOTIDES IN MICE
      Dagmar Fischer, Berit Osburg, Holger Petersen, Thomas Kissel and Ulrich Bickel
      Drug Metabolism and Disposition September 2004, 32 (9) 983-992;

  5. Blair, Ian A.

    1. KINETICS AND REGULATION OF CYTOCHROME P450-MEDIATED ETOPOSIDE METABOLISM
      Xiaoliang Zhuo, Naiyu Zheng, Carolyn A. Felix and Ian A. Blair
      Drug Metabolism and Disposition September 2004, 32 (9) 993-1000;

  6. Breyer-Pfaff, Ursula

    1. ENANTIOSELECTIVITY OF CARBONYL REDUCTION OF 4-METHYLNITROSAMINO-1-(3-PYRIDYL)-1-BUTANONE BY TISSUE FRACTIONS FROM HUMAN AND RAT AND BY ENZYMES ISOLATED FROM HUMAN LIVER
      Ursula Breyer-Pfaff, Hans-Jörg Martin, Michael Ernst and Edmund Maser
      Drug Metabolism and Disposition September 2004, 32 (9) 915-922;

C

  1. Chavin, Kenneth D.

    1. GREEN TEA (CAMELLIA SINENSIS) EXTRACT DOES NOT ALTER CYTOCHROME P450 3A4 OR 2D6 ACTIVITY IN HEALTHY VOLUNTEERS
      Jennifer L. Donovan, Kenneth D. Chavin, C. Lindsay Devane, Robin M. Taylor, Jun-Sheng Wang, Ying Ruan and John S. Markowitz
      Drug Metabolism and Disposition September 2004, 32 (9) 906-908; DOI: https://doi.org/10.1124/dmd.104.000083

  2. Chen, Yung-Hsiang

    1. EVALUATION OF A NOVEL IN VITRO CACO-2 HEPATOCYTE HYBRID SYSTEM FOR PREDICTING IN VIVO ORAL BIOAVAILABILITY
      Yau Yi Lau, Yung-Hsiang Chen, Tong-tong Liu, Cheng Li, Xiaoming Cui, Ronald E. White and K.-C. Cheng
      Drug Metabolism and Disposition September 2004, 32 (9) 937-942;

  3. Cheng, K.-C.

    1. EVALUATION OF A NOVEL IN VITRO CACO-2 HEPATOCYTE HYBRID SYSTEM FOR PREDICTING IN VIVO ORAL BIOAVAILABILITY
      Yau Yi Lau, Yung-Hsiang Chen, Tong-tong Liu, Cheng Li, Xiaoming Cui, Ronald E. White and K.-C. Cheng
      Drug Metabolism and Disposition September 2004, 32 (9) 937-942;

  4. Cho, Il Je

    1. CERAMIDE, AN APOPTOTIC RHEOSTAT, INHIBITS CCAAT/ENHANCER BINDING PROTEIN-β AND NF-E2-RELATED FACTOR-2 ACTIVATION: THE ROLE IN GLUTATHIONE S-TRANSFERASE A2 GENE REPRESSION
      I-Na Park, Il Je Cho and Sang Geon Kim
      Drug Metabolism and Disposition September 2004, 32 (9) 893-897;

  5. Collins, Kathy S.

    1. BIOACTIVATION OF 1,1-DICHLOROETHYLENE TO ITS EPOXIDE BY CYP2E1 AND CYP2F ENZYMES
      Andrea C. Simmonds, Christopher A. Reilly, R. Michael Baldwin, Burhan I. Ghanayem, Diane L. Lanza, Garold S. Yost, Kathy S. Collins and Poh-Gek Forkert
      Drug Metabolism and Disposition September 2004, 32 (9) 1032-1039;

  6. Cui, Xiaoming

    1. EVALUATION OF A NOVEL IN VITRO CACO-2 HEPATOCYTE HYBRID SYSTEM FOR PREDICTING IN VIVO ORAL BIOAVAILABILITY
      Yau Yi Lau, Yung-Hsiang Chen, Tong-tong Liu, Cheng Li, Xiaoming Cui, Ronald E. White and K.-C. Cheng
      Drug Metabolism and Disposition September 2004, 32 (9) 937-942;

D

  1. Davidson, Rita S.

    1. SELECTIVE REDUCTION OF N-OXIDES TO AMINES: APPLICATION TO DRUG METABOLISM
      Palaniappan Kulanthaivel, Robert J. Barbuch, Rita S. Davidson, Ping Yi, Gregory A. Rener, Edward L. Mattiuz, Chad E. Hadden, Lawrence A. Goodwin and William J. Ehlhardt
      Drug Metabolism and Disposition September 2004, 32 (9) 966-972;

  2. Dean, Dennis

    1. IN VITRO METABOLISM OF MK-0767 [(±)-5-[(2,4-DIOXOTHIAZOLIDIN-5-YL)METHYL]-2-METHOXY-N-[[(4-TRIFLUOROMETHYL) PHENYL]METHYL]BENZAMIDE], A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α/γ AGONIST. I. ROLE OF CYTOCHROME P450, METHYLTRANSFERASES, FLAVIN MONOOXYGENASES, AND ESTERASES
      Bindhu V. Karanam, Cornelis E.C.A. Hop, David Q. Liu, Mike Wallace, Dennis Dean, Hiroya Satoh, Masakatsu Komuro, Katsuya Awano and Stella H. Vincent
      Drug Metabolism and Disposition September 2004, 32 (9) 1015-1022; DOI: https://doi.org/10.1124/dmd.104.000034

  3. de la Torre, Rafael

    1. STEREOCHEMICAL ANALYSIS OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE AND ITS MAIN METABOLITES IN HUMAN SAMPLES INCLUDING THE CATECHOL-TYPE METABOLITE (3,4-DIHYDROXYMETHAMPHETAMINE)
      Nieves Pizarro, Magí Farré, Mitona Pujadas, Ana Ma͢ Peiró, Pere N Roset, Jesús Joglar and Rafael de la Torre
      Drug Metabolism and Disposition September 2004, 32 (9) 1001-1007;

  4. Devane, C. Lindsay

    1. GREEN TEA (CAMELLIA SINENSIS) EXTRACT DOES NOT ALTER CYTOCHROME P450 3A4 OR 2D6 ACTIVITY IN HEALTHY VOLUNTEERS
      Jennifer L. Donovan, Kenneth D. Chavin, C. Lindsay Devane, Robin M. Taylor, Jun-Sheng Wang, Ying Ruan and John S. Markowitz
      Drug Metabolism and Disposition September 2004, 32 (9) 906-908; DOI: https://doi.org/10.1124/dmd.104.000083

  5. Donovan, Jennifer L.

    1. GREEN TEA (CAMELLIA SINENSIS) EXTRACT DOES NOT ALTER CYTOCHROME P450 3A4 OR 2D6 ACTIVITY IN HEALTHY VOLUNTEERS
      Jennifer L. Donovan, Kenneth D. Chavin, C. Lindsay Devane, Robin M. Taylor, Jun-Sheng Wang, Ying Ruan and John S. Markowitz
      Drug Metabolism and Disposition September 2004, 32 (9) 906-908; DOI: https://doi.org/10.1124/dmd.104.000083

  6. Doss, George A.

    1. IN VITRO METABOLISM OF MK-0767 [(±)-5-[(2,4-DIOXOTHIAZOLIDIN-5-YL)METHYL]-2-METHOXY-N-[[(4-TRIFLUOROMETHYL)-PHENYL] METHYL]BENZAMIDE], A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α/γ AGONIST. II. IDENTIFICATION OF METABOLITES BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY
      David Q. Liu, Bindhu V. Karanam, George A. Doss, Rick R. Sidler, Stella H. Vincent and Cornelis E.C.A. Hop
      Drug Metabolism and Disposition September 2004, 32 (9) 1023-1031; DOI: https://doi.org/10.1124/dmd.104.000059

E

  1. Ehlhardt, William J.

    1. SELECTIVE REDUCTION OF N-OXIDES TO AMINES: APPLICATION TO DRUG METABOLISM
      Palaniappan Kulanthaivel, Robert J. Barbuch, Rita S. Davidson, Ping Yi, Gregory A. Rener, Edward L. Mattiuz, Chad E. Hadden, Lawrence A. Goodwin and William J. Ehlhardt
      Drug Metabolism and Disposition September 2004, 32 (9) 966-972;

  2. Elebring, M.

    1. PHARMACOKINETICS AND METABOLISM OF TESAGLITAZAR, A NOVEL DUAL-ACTING PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α/γ AGONIST, AFTER A SINGLE ORAL AND INTRAVENOUS DOSE IN HUMANS
      H. Ericsson, B. Hamrén, S. Bergstrand, M. Elebring, L. Fryklund, M. Heijer and K. P. Öhman
      Drug Metabolism and Disposition September 2004, 32 (9) 923-929;

  3. Endou, Hitoshi

    1. CARRIER-MEDIATED UPTAKE OF H2-RECEPTOR ANTAGONISTS BY THE RAT CHOROID PLEXUS: INVOLVEMENT OF RAT ORGANIC ANION TRANSPORTER 3
      Yoshinori Nagata, Hiroyuki Kusuhara, Shuichi Hirono, Hitoshi Endou and Yuichi Sugiyama
      Drug Metabolism and Disposition September 2004, 32 (9) 1040-1047;

  4. Ericsson, H.

    1. PHARMACOKINETICS AND METABOLISM OF TESAGLITAZAR, A NOVEL DUAL-ACTING PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α/γ AGONIST, AFTER A SINGLE ORAL AND INTRAVENOUS DOSE IN HUMANS
      H. Ericsson, B. Hamrén, S. Bergstrand, M. Elebring, L. Fryklund, M. Heijer and K. P. Öhman
      Drug Metabolism and Disposition September 2004, 32 (9) 923-929;

  5. Ernst, Michael

    1. ENANTIOSELECTIVITY OF CARBONYL REDUCTION OF 4-METHYLNITROSAMINO-1-(3-PYRIDYL)-1-BUTANONE BY TISSUE FRACTIONS FROM HUMAN AND RAT AND BY ENZYMES ISOLATED FROM HUMAN LIVER
      Ursula Breyer-Pfaff, Hans-Jörg Martin, Michael Ernst and Edmund Maser
      Drug Metabolism and Disposition September 2004, 32 (9) 915-922;

F

  1. Farré, Magí

    1. STEREOCHEMICAL ANALYSIS OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE AND ITS MAIN METABOLITES IN HUMAN SAMPLES INCLUDING THE CATECHOL-TYPE METABOLITE (3,4-DIHYDROXYMETHAMPHETAMINE)
      Nieves Pizarro, Magí Farré, Mitona Pujadas, Ana Ma͢ Peiró, Pere N Roset, Jesús Joglar and Rafael de la Torre
      Drug Metabolism and Disposition September 2004, 32 (9) 1001-1007;

  2. Felix, Carolyn A.

    1. KINETICS AND REGULATION OF CYTOCHROME P450-MEDIATED ETOPOSIDE METABOLISM
      Xiaoliang Zhuo, Naiyu Zheng, Carolyn A. Felix and Ian A. Blair
      Drug Metabolism and Disposition September 2004, 32 (9) 993-1000;

  3. Fischer, Dagmar

    1. EFFECT OF POLY(ETHYLENE IMINE) MOLECULAR WEIGHT AND PEGYLATION ON ORGAN DISTRIBUTION AND PHARMACOKINETICS OF POLYPLEXES WITH OLIGODEOXYNUCLEOTIDES IN MICE
      Dagmar Fischer, Berit Osburg, Holger Petersen, Thomas Kissel and Ulrich Bickel
      Drug Metabolism and Disposition September 2004, 32 (9) 983-992;

  4. Flockhart, David A.

    1. CYP2B6, CYP3A4, AND CYP2C19 ARE RESPONSIBLE FOR THE IN VITRO N-DEMETHYLATION OF MEPERIDINE IN HUMAN LIVER MICROSOMES
      Jacqueline Ramírez, Federico Innocenti, Erin G. Schuetz, David A. Flockhart, Mary V. Relling, Raymond Santucci and Mark J. Ratain
      Drug Metabolism and Disposition September 2004, 32 (9) 930-936;

  5. Forkert, Poh-Gek

    1. BIOACTIVATION OF 1,1-DICHLOROETHYLENE TO ITS EPOXIDE BY CYP2E1 AND CYP2F ENZYMES
      Andrea C. Simmonds, Christopher A. Reilly, R. Michael Baldwin, Burhan I. Ghanayem, Diane L. Lanza, Garold S. Yost, Kathy S. Collins and Poh-Gek Forkert
      Drug Metabolism and Disposition September 2004, 32 (9) 1032-1039;

  6. Franklin, Ronald B.

    1. DIFFERENCES IN THE PHARMACOKINETICS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONISTS IN GENETICALLY OBESE ZUCKER AND SPRAGUE-DAWLEY RATS: IMPLICATIONS OF DECREASED GLUCURONIDATION IN OBESE ZUCKER RATS
      Mi-Sook Kim, Sui Wang, Zhongzhou Shen, Christopher J. Kochansky, John R. Strauss, Ronald B. Franklin and Stella H. Vincent
      Drug Metabolism and Disposition September 2004, 32 (9) 909-914;

  7. Fryklund, L.

    1. PHARMACOKINETICS AND METABOLISM OF TESAGLITAZAR, A NOVEL DUAL-ACTING PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α/γ AGONIST, AFTER A SINGLE ORAL AND INTRAVENOUS DOSE IN HUMANS
      H. Ericsson, B. Hamrén, S. Bergstrand, M. Elebring, L. Fryklund, M. Heijer and K. P. Öhman
      Drug Metabolism and Disposition September 2004, 32 (9) 923-929;

  8. Fujita, Shoichi

    1. STRAIN DIFFERENCES IN DIAZEPAM METABOLISM AT ITS THREE METABOLIC SITES IN SPRAGUE-DAWLEY, BROWN NORWAY, DARK AGOUTI, AND WISTAR STRAIN RATS
      Konomu Saito, Noriaki Sakai, Hyung-Sub Kim, Mayumi Ishizuka, Akio Kazusaka and Shoichi Fujita
      Drug Metabolism and Disposition September 2004, 32 (9) 959-965;

G

  1. Ghanayem, Burhan I.

    1. BIOACTIVATION OF 1,1-DICHLOROETHYLENE TO ITS EPOXIDE BY CYP2E1 AND CYP2F ENZYMES
      Andrea C. Simmonds, Christopher A. Reilly, R. Michael Baldwin, Burhan I. Ghanayem, Diane L. Lanza, Garold S. Yost, Kathy S. Collins and Poh-Gek Forkert
      Drug Metabolism and Disposition September 2004, 32 (9) 1032-1039;

  2. Goodwin, Lawrence A.

    1. SELECTIVE REDUCTION OF N-OXIDES TO AMINES: APPLICATION TO DRUG METABOLISM
      Palaniappan Kulanthaivel, Robert J. Barbuch, Rita S. Davidson, Ping Yi, Gregory A. Rener, Edward L. Mattiuz, Chad E. Hadden, Lawrence A. Goodwin and William J. Ehlhardt
      Drug Metabolism and Disposition September 2004, 32 (9) 966-972;

H

  1. Hadden, Chad E.

    1. SELECTIVE REDUCTION OF N-OXIDES TO AMINES: APPLICATION TO DRUG METABOLISM
      Palaniappan Kulanthaivel, Robert J. Barbuch, Rita S. Davidson, Ping Yi, Gregory A. Rener, Edward L. Mattiuz, Chad E. Hadden, Lawrence A. Goodwin and William J. Ehlhardt
      Drug Metabolism and Disposition September 2004, 32 (9) 966-972;

  2. Hamrén, B.

    1. PHARMACOKINETICS AND METABOLISM OF TESAGLITAZAR, A NOVEL DUAL-ACTING PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α/γ AGONIST, AFTER A SINGLE ORAL AND INTRAVENOUS DOSE IN HUMANS
      H. Ericsson, B. Hamrén, S. Bergstrand, M. Elebring, L. Fryklund, M. Heijer and K. P. Öhman
      Drug Metabolism and Disposition September 2004, 32 (9) 923-929;

  3. Heijer, M.

    1. PHARMACOKINETICS AND METABOLISM OF TESAGLITAZAR, A NOVEL DUAL-ACTING PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α/γ AGONIST, AFTER A SINGLE ORAL AND INTRAVENOUS DOSE IN HUMANS
      H. Ericsson, B. Hamrén, S. Bergstrand, M. Elebring, L. Fryklund, M. Heijer and K. P. Öhman
      Drug Metabolism and Disposition September 2004, 32 (9) 923-929;

  4. Hirono, Shuichi

    1. CARRIER-MEDIATED UPTAKE OF H2-RECEPTOR ANTAGONISTS BY THE RAT CHOROID PLEXUS: INVOLVEMENT OF RAT ORGANIC ANION TRANSPORTER 3
      Yoshinori Nagata, Hiroyuki Kusuhara, Shuichi Hirono, Hitoshi Endou and Yuichi Sugiyama
      Drug Metabolism and Disposition September 2004, 32 (9) 1040-1047;

  5. Hop, Cornelis E.C.A.

    1. IN VITRO METABOLISM OF MK-0767 [(±)-5-[(2,4-DIOXOTHIAZOLIDIN-5-YL)METHYL]-2-METHOXY-N-[[(4-TRIFLUOROMETHYL) PHENYL]METHYL]BENZAMIDE], A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α/γ AGONIST. I. ROLE OF CYTOCHROME P450, METHYLTRANSFERASES, FLAVIN MONOOXYGENASES, AND ESTERASES
      Bindhu V. Karanam, Cornelis E.C.A. Hop, David Q. Liu, Mike Wallace, Dennis Dean, Hiroya Satoh, Masakatsu Komuro, Katsuya Awano and Stella H. Vincent
      Drug Metabolism and Disposition September 2004, 32 (9) 1015-1022; DOI: https://doi.org/10.1124/dmd.104.000034
    2. IN VITRO METABOLISM OF MK-0767 [(±)-5-[(2,4-DIOXOTHIAZOLIDIN-5-YL)METHYL]-2-METHOXY-N-[[(4-TRIFLUOROMETHYL)-PHENYL] METHYL]BENZAMIDE], A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α/γ AGONIST. II. IDENTIFICATION OF METABOLITES BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY
      David Q. Liu, Bindhu V. Karanam, George A. Doss, Rick R. Sidler, Stella H. Vincent and Cornelis E.C.A. Hop
      Drug Metabolism and Disposition September 2004, 32 (9) 1023-1031; DOI: https://doi.org/10.1124/dmd.104.000059

  6. Houston, J. Brian

    1. SUBSTRATE DEPLETION APPROACH FOR DETERMINING IN VITRO METABOLIC CLEARANCE: TIME DEPENDENCIES IN HEPATOCYTE AND MICROSOMAL INCUBATIONS
      Hannah M. Jones and J. Brian Houston
      Drug Metabolism and Disposition September 2004, 32 (9) 973-982; DOI: https://doi.org/10.1124/dmd.104.000125

I

  1. Innocenti, Federico

    1. CYP2B6, CYP3A4, AND CYP2C19 ARE RESPONSIBLE FOR THE IN VITRO N-DEMETHYLATION OF MEPERIDINE IN HUMAN LIVER MICROSOMES
      Jacqueline Ramírez, Federico Innocenti, Erin G. Schuetz, David A. Flockhart, Mary V. Relling, Raymond Santucci and Mark J. Ratain
      Drug Metabolism and Disposition September 2004, 32 (9) 930-936;

  2. Ishizuka, Mayumi

    1. STRAIN DIFFERENCES IN DIAZEPAM METABOLISM AT ITS THREE METABOLIC SITES IN SPRAGUE-DAWLEY, BROWN NORWAY, DARK AGOUTI, AND WISTAR STRAIN RATS
      Konomu Saito, Noriaki Sakai, Hyung-Sub Kim, Mayumi Ishizuka, Akio Kazusaka and Shoichi Fujita
      Drug Metabolism and Disposition September 2004, 32 (9) 959-965;

J

  1. Jinno, Hideto

    1. SINGLE NUCLEOTIDE POLYMORPHISMS AND HAPLOTYPE FREQUENCIES OF UGT2B4 AND UGT2B7 IN A JAPANESE POPULATION
      Mayumi Saeki, Yoshiro Saito, Hideto Jinno, Toshiko Tanaka-Kagawa, Akiko Ohno, Shogo Ozawa, Kazuyuki Ueno, Shiro Kamakura, Naoyuki Kamatani, Kazuo Komamura, Masafumi Kitakaze and Jun-ichi Sawada
      Drug Metabolism and Disposition September 2004, 32 (9) 1048-1054;

  2. Joglar, Jesús

    1. STEREOCHEMICAL ANALYSIS OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE AND ITS MAIN METABOLITES IN HUMAN SAMPLES INCLUDING THE CATECHOL-TYPE METABOLITE (3,4-DIHYDROXYMETHAMPHETAMINE)
      Nieves Pizarro, Magí Farré, Mitona Pujadas, Ana Ma͢ Peiró, Pere N Roset, Jesús Joglar and Rafael de la Torre
      Drug Metabolism and Disposition September 2004, 32 (9) 1001-1007;

  3. Jones, Hannah M.

    1. SUBSTRATE DEPLETION APPROACH FOR DETERMINING IN VITRO METABOLIC CLEARANCE: TIME DEPENDENCIES IN HEPATOCYTE AND MICROSOMAL INCUBATIONS
      Hannah M. Jones and J. Brian Houston
      Drug Metabolism and Disposition September 2004, 32 (9) 973-982; DOI: https://doi.org/10.1124/dmd.104.000125

  4. Jonker, Johan W.

    1. IMPAIRED RENAL EXCRETION OF 6-HYDROXY-5,7-DIMETHYL-2-METHYLAMINO-4-(3-PYRIDYLMETHYL) BENZOTHIAZOLE (E3040) SULFATE IN BREAST CANCER RESISTANCE PROTEIN (BCRP1/ABCG2) KNOCKOUT MICE
      Naomi Mizuno, Michiko Suzuki, Hiroyuki Kusuhara, Hiroshi Suzuki, Kenji Takeuchi, Takuro Niwa, Johan W. Jonker and Yuichi Sugiyama
      Drug Metabolism and Disposition September 2004, 32 (9) 898-901;

K

  1. Kalgutkar, Amit S.

    1. IDENTIFICATION OF AN N-METHYL-4-PHENYLPYRIDINIUM-LIKE METABOLITE OF THE ANTIDIARRHEAL AGENT LOPERAMIDE IN HUMAN LIVER MICROSOMES: UNDERLYING REASON(S) FOR THE LACK OF NEUROTOXICITY DESPITE THE BIOACTIVATION EVENT
      Amit S. Kalgutkar and Hang T. Nguyen
      Drug Metabolism and Disposition September 2004, 32 (9) 943-952;

  2. Kamakura, Shiro

    1. SINGLE NUCLEOTIDE POLYMORPHISMS AND HAPLOTYPE FREQUENCIES OF UGT2B4 AND UGT2B7 IN A JAPANESE POPULATION
      Mayumi Saeki, Yoshiro Saito, Hideto Jinno, Toshiko Tanaka-Kagawa, Akiko Ohno, Shogo Ozawa, Kazuyuki Ueno, Shiro Kamakura, Naoyuki Kamatani, Kazuo Komamura, Masafumi Kitakaze and Jun-ichi Sawada
      Drug Metabolism and Disposition September 2004, 32 (9) 1048-1054;

  3. Kamatani, Naoyuki

    1. SINGLE NUCLEOTIDE POLYMORPHISMS AND HAPLOTYPE FREQUENCIES OF UGT2B4 AND UGT2B7 IN A JAPANESE POPULATION
      Mayumi Saeki, Yoshiro Saito, Hideto Jinno, Toshiko Tanaka-Kagawa, Akiko Ohno, Shogo Ozawa, Kazuyuki Ueno, Shiro Kamakura, Naoyuki Kamatani, Kazuo Komamura, Masafumi Kitakaze and Jun-ichi Sawada
      Drug Metabolism and Disposition September 2004, 32 (9) 1048-1054;

  4. Karanam, Bindhu V.

    1. IN VITRO METABOLISM OF MK-0767 [(±)-5-[(2,4-DIOXOTHIAZOLIDIN-5-YL)METHYL]-2-METHOXY-N-[[(4-TRIFLUOROMETHYL) PHENYL]METHYL]BENZAMIDE], A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α/γ AGONIST. I. ROLE OF CYTOCHROME P450, METHYLTRANSFERASES, FLAVIN MONOOXYGENASES, AND ESTERASES
      Bindhu V. Karanam, Cornelis E.C.A. Hop, David Q. Liu, Mike Wallace, Dennis Dean, Hiroya Satoh, Masakatsu Komuro, Katsuya Awano and Stella H. Vincent
      Drug Metabolism and Disposition September 2004, 32 (9) 1015-1022; DOI: https://doi.org/10.1124/dmd.104.000034
    2. IN VITRO METABOLISM OF MK-0767 [(±)-5-[(2,4-DIOXOTHIAZOLIDIN-5-YL)METHYL]-2-METHOXY-N-[[(4-TRIFLUOROMETHYL)-PHENYL] METHYL]BENZAMIDE], A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α/γ AGONIST. II. IDENTIFICATION OF METABOLITES BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY
      David Q. Liu, Bindhu V. Karanam, George A. Doss, Rick R. Sidler, Stella H. Vincent and Cornelis E.C.A. Hop
      Drug Metabolism and Disposition September 2004, 32 (9) 1023-1031; DOI: https://doi.org/10.1124/dmd.104.000059

  5. Kazusaka, Akio

    1. STRAIN DIFFERENCES IN DIAZEPAM METABOLISM AT ITS THREE METABOLIC SITES IN SPRAGUE-DAWLEY, BROWN NORWAY, DARK AGOUTI, AND WISTAR STRAIN RATS
      Konomu Saito, Noriaki Sakai, Hyung-Sub Kim, Mayumi Ishizuka, Akio Kazusaka and Shoichi Fujita
      Drug Metabolism and Disposition September 2004, 32 (9) 959-965;

  6. Kim, Hyung-Sub

    1. STRAIN DIFFERENCES IN DIAZEPAM METABOLISM AT ITS THREE METABOLIC SITES IN SPRAGUE-DAWLEY, BROWN NORWAY, DARK AGOUTI, AND WISTAR STRAIN RATS
      Konomu Saito, Noriaki Sakai, Hyung-Sub Kim, Mayumi Ishizuka, Akio Kazusaka and Shoichi Fujita
      Drug Metabolism and Disposition September 2004, 32 (9) 959-965;

  7. Kim, Mi-Sook

    1. DIFFERENCES IN THE PHARMACOKINETICS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONISTS IN GENETICALLY OBESE ZUCKER AND SPRAGUE-DAWLEY RATS: IMPLICATIONS OF DECREASED GLUCURONIDATION IN OBESE ZUCKER RATS
      Mi-Sook Kim, Sui Wang, Zhongzhou Shen, Christopher J. Kochansky, John R. Strauss, Ronald B. Franklin and Stella H. Vincent
      Drug Metabolism and Disposition September 2004, 32 (9) 909-914;

  8. Kim, Sang Geon

    1. CERAMIDE, AN APOPTOTIC RHEOSTAT, INHIBITS CCAAT/ENHANCER BINDING PROTEIN-β AND NF-E2-RELATED FACTOR-2 ACTIVATION: THE ROLE IN GLUTATHIONE S-TRANSFERASE A2 GENE REPRESSION
      I-Na Park, Il Je Cho and Sang Geon Kim
      Drug Metabolism and Disposition September 2004, 32 (9) 893-897;

  9. Kissel, Thomas

    1. EFFECT OF POLY(ETHYLENE IMINE) MOLECULAR WEIGHT AND PEGYLATION ON ORGAN DISTRIBUTION AND PHARMACOKINETICS OF POLYPLEXES WITH OLIGODEOXYNUCLEOTIDES IN MICE
      Dagmar Fischer, Berit Osburg, Holger Petersen, Thomas Kissel and Ulrich Bickel
      Drug Metabolism and Disposition September 2004, 32 (9) 983-992;

  10. Kitakaze, Masafumi

    1. SINGLE NUCLEOTIDE POLYMORPHISMS AND HAPLOTYPE FREQUENCIES OF UGT2B4 AND UGT2B7 IN A JAPANESE POPULATION
      Mayumi Saeki, Yoshiro Saito, Hideto Jinno, Toshiko Tanaka-Kagawa, Akiko Ohno, Shogo Ozawa, Kazuyuki Ueno, Shiro Kamakura, Naoyuki Kamatani, Kazuo Komamura, Masafumi Kitakaze and Jun-ichi Sawada
      Drug Metabolism and Disposition September 2004, 32 (9) 1048-1054;

  11. Kochansky, Christopher J.

    1. DIFFERENCES IN THE PHARMACOKINETICS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONISTS IN GENETICALLY OBESE ZUCKER AND SPRAGUE-DAWLEY RATS: IMPLICATIONS OF DECREASED GLUCURONIDATION IN OBESE ZUCKER RATS
      Mi-Sook Kim, Sui Wang, Zhongzhou Shen, Christopher J. Kochansky, John R. Strauss, Ronald B. Franklin and Stella H. Vincent
      Drug Metabolism and Disposition September 2004, 32 (9) 909-914;

  12. Komamura, Kazuo

    1. SINGLE NUCLEOTIDE POLYMORPHISMS AND HAPLOTYPE FREQUENCIES OF UGT2B4 AND UGT2B7 IN A JAPANESE POPULATION
      Mayumi Saeki, Yoshiro Saito, Hideto Jinno, Toshiko Tanaka-Kagawa, Akiko Ohno, Shogo Ozawa, Kazuyuki Ueno, Shiro Kamakura, Naoyuki Kamatani, Kazuo Komamura, Masafumi Kitakaze and Jun-ichi Sawada
      Drug Metabolism and Disposition September 2004, 32 (9) 1048-1054;

  13. Komuro, Masakatsu

    1. IN VITRO METABOLISM OF MK-0767 [(±)-5-[(2,4-DIOXOTHIAZOLIDIN-5-YL)METHYL]-2-METHOXY-N-[[(4-TRIFLUOROMETHYL) PHENYL]METHYL]BENZAMIDE], A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α/γ AGONIST. I. ROLE OF CYTOCHROME P450, METHYLTRANSFERASES, FLAVIN MONOOXYGENASES, AND ESTERASES
      Bindhu V. Karanam, Cornelis E.C.A. Hop, David Q. Liu, Mike Wallace, Dennis Dean, Hiroya Satoh, Masakatsu Komuro, Katsuya Awano and Stella H. Vincent
      Drug Metabolism and Disposition September 2004, 32 (9) 1015-1022; DOI: https://doi.org/10.1124/dmd.104.000034

  14. Kulanthaivel, Palaniappan

    1. SELECTIVE REDUCTION OF N-OXIDES TO AMINES: APPLICATION TO DRUG METABOLISM
      Palaniappan Kulanthaivel, Robert J. Barbuch, Rita S. Davidson, Ping Yi, Gregory A. Rener, Edward L. Mattiuz, Chad E. Hadden, Lawrence A. Goodwin and William J. Ehlhardt
      Drug Metabolism and Disposition September 2004, 32 (9) 966-972;

  15. Kusuhara, Hiroyuki

    1. CARRIER-MEDIATED UPTAKE OF H2-RECEPTOR ANTAGONISTS BY THE RAT CHOROID PLEXUS: INVOLVEMENT OF RAT ORGANIC ANION TRANSPORTER 3
      Yoshinori Nagata, Hiroyuki Kusuhara, Shuichi Hirono, Hitoshi Endou and Yuichi Sugiyama
      Drug Metabolism and Disposition September 2004, 32 (9) 1040-1047;
    2. IMPAIRED RENAL EXCRETION OF 6-HYDROXY-5,7-DIMETHYL-2-METHYLAMINO-4-(3-PYRIDYLMETHYL) BENZOTHIAZOLE (E3040) SULFATE IN BREAST CANCER RESISTANCE PROTEIN (BCRP1/ABCG2) KNOCKOUT MICE
      Naomi Mizuno, Michiko Suzuki, Hiroyuki Kusuhara, Hiroshi Suzuki, Kenji Takeuchi, Takuro Niwa, Johan W. Jonker and Yuichi Sugiyama
      Drug Metabolism and Disposition September 2004, 32 (9) 898-901;

L

  1. Lanza, Diane L.

    1. BIOACTIVATION OF 1,1-DICHLOROETHYLENE TO ITS EPOXIDE BY CYP2E1 AND CYP2F ENZYMES
      Andrea C. Simmonds, Christopher A. Reilly, R. Michael Baldwin, Burhan I. Ghanayem, Diane L. Lanza, Garold S. Yost, Kathy S. Collins and Poh-Gek Forkert
      Drug Metabolism and Disposition September 2004, 32 (9) 1032-1039;

  2. Lau, Yau Yi

    1. EVALUATION OF A NOVEL IN VITRO CACO-2 HEPATOCYTE HYBRID SYSTEM FOR PREDICTING IN VIVO ORAL BIOAVAILABILITY
      Yau Yi Lau, Yung-Hsiang Chen, Tong-tong Liu, Cheng Li, Xiaoming Cui, Ronald E. White and K.-C. Cheng
      Drug Metabolism and Disposition September 2004, 32 (9) 937-942;

  3. Li, Cheng

    1. EVALUATION OF A NOVEL IN VITRO CACO-2 HEPATOCYTE HYBRID SYSTEM FOR PREDICTING IN VIVO ORAL BIOAVAILABILITY
      Yau Yi Lau, Yung-Hsiang Chen, Tong-tong Liu, Cheng Li, Xiaoming Cui, Ronald E. White and K.-C. Cheng
      Drug Metabolism and Disposition September 2004, 32 (9) 937-942;

  4. Liu, David Q.

    1. IN VITRO METABOLISM OF MK-0767 [(±)-5-[(2,4-DIOXOTHIAZOLIDIN-5-YL)METHYL]-2-METHOXY-N-[[(4-TRIFLUOROMETHYL) PHENYL]METHYL]BENZAMIDE], A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α/γ AGONIST. I. ROLE OF CYTOCHROME P450, METHYLTRANSFERASES, FLAVIN MONOOXYGENASES, AND ESTERASES
      Bindhu V. Karanam, Cornelis E.C.A. Hop, David Q. Liu, Mike Wallace, Dennis Dean, Hiroya Satoh, Masakatsu Komuro, Katsuya Awano and Stella H. Vincent
      Drug Metabolism and Disposition September 2004, 32 (9) 1015-1022; DOI: https://doi.org/10.1124/dmd.104.000034
    2. IN VITRO METABOLISM OF MK-0767 [(±)-5-[(2,4-DIOXOTHIAZOLIDIN-5-YL)METHYL]-2-METHOXY-N-[[(4-TRIFLUOROMETHYL)-PHENYL] METHYL]BENZAMIDE], A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α/γ AGONIST. II. IDENTIFICATION OF METABOLITES BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY
      David Q. Liu, Bindhu V. Karanam, George A. Doss, Rick R. Sidler, Stella H. Vincent and Cornelis E.C.A. Hop
      Drug Metabolism and Disposition September 2004, 32 (9) 1023-1031; DOI: https://doi.org/10.1124/dmd.104.000059

  5. Liu, Tong-tong

    1. EVALUATION OF A NOVEL IN VITRO CACO-2 HEPATOCYTE HYBRID SYSTEM FOR PREDICTING IN VIVO ORAL BIOAVAILABILITY
      Yau Yi Lau, Yung-Hsiang Chen, Tong-tong Liu, Cheng Li, Xiaoming Cui, Ronald E. White and K.-C. Cheng
      Drug Metabolism and Disposition September 2004, 32 (9) 937-942;

M

  1. Markowitz, John S.

    1. GREEN TEA (CAMELLIA SINENSIS) EXTRACT DOES NOT ALTER CYTOCHROME P450 3A4 OR 2D6 ACTIVITY IN HEALTHY VOLUNTEERS
      Jennifer L. Donovan, Kenneth D. Chavin, C. Lindsay Devane, Robin M. Taylor, Jun-Sheng Wang, Ying Ruan and John S. Markowitz
      Drug Metabolism and Disposition September 2004, 32 (9) 906-908; DOI: https://doi.org/10.1124/dmd.104.000083

  2. Martin, Hans-Jörg

    1. ENANTIOSELECTIVITY OF CARBONYL REDUCTION OF 4-METHYLNITROSAMINO-1-(3-PYRIDYL)-1-BUTANONE BY TISSUE FRACTIONS FROM HUMAN AND RAT AND BY ENZYMES ISOLATED FROM HUMAN LIVER
      Ursula Breyer-Pfaff, Hans-Jörg Martin, Michael Ernst and Edmund Maser
      Drug Metabolism and Disposition September 2004, 32 (9) 915-922;

  3. Maser, Edmund

    1. ENANTIOSELECTIVITY OF CARBONYL REDUCTION OF 4-METHYLNITROSAMINO-1-(3-PYRIDYL)-1-BUTANONE BY TISSUE FRACTIONS FROM HUMAN AND RAT AND BY ENZYMES ISOLATED FROM HUMAN LIVER
      Ursula Breyer-Pfaff, Hans-Jörg Martin, Michael Ernst and Edmund Maser
      Drug Metabolism and Disposition September 2004, 32 (9) 915-922;

  4. Matheny, Christopher J.

    1. EFFECT OF PROTOTYPICAL INDUCING AGENTS ON P-GLYCOPROTEIN AND CYP3A EXPRESSION IN MOUSE TISSUES
      Christopher J. Matheny, Rabia Y. Ali, Xiaodong Yang and Gary M. Pollack
      Drug Metabolism and Disposition September 2004, 32 (9) 1008-1014;

  5. Mattiuz, Edward L.

    1. SELECTIVE REDUCTION OF N-OXIDES TO AMINES: APPLICATION TO DRUG METABOLISM
      Palaniappan Kulanthaivel, Robert J. Barbuch, Rita S. Davidson, Ping Yi, Gregory A. Rener, Edward L. Mattiuz, Chad E. Hadden, Lawrence A. Goodwin and William J. Ehlhardt
      Drug Metabolism and Disposition September 2004, 32 (9) 966-972;

  6. Mizuno, Naomi

    1. IMPAIRED RENAL EXCRETION OF 6-HYDROXY-5,7-DIMETHYL-2-METHYLAMINO-4-(3-PYRIDYLMETHYL) BENZOTHIAZOLE (E3040) SULFATE IN BREAST CANCER RESISTANCE PROTEIN (BCRP1/ABCG2) KNOCKOUT MICE
      Naomi Mizuno, Michiko Suzuki, Hiroyuki Kusuhara, Hiroshi Suzuki, Kenji Takeuchi, Takuro Niwa, Johan W. Jonker and Yuichi Sugiyama
      Drug Metabolism and Disposition September 2004, 32 (9) 898-901;

N

  1. Nagata, Yoshinori

    1. CARRIER-MEDIATED UPTAKE OF H2-RECEPTOR ANTAGONISTS BY THE RAT CHOROID PLEXUS: INVOLVEMENT OF RAT ORGANIC ANION TRANSPORTER 3
      Yoshinori Nagata, Hiroyuki Kusuhara, Shuichi Hirono, Hitoshi Endou and Yuichi Sugiyama
      Drug Metabolism and Disposition September 2004, 32 (9) 1040-1047;

  2. Nguyen, Hang T.

    1. IDENTIFICATION OF AN N-METHYL-4-PHENYLPYRIDINIUM-LIKE METABOLITE OF THE ANTIDIARRHEAL AGENT LOPERAMIDE IN HUMAN LIVER MICROSOMES: UNDERLYING REASON(S) FOR THE LACK OF NEUROTOXICITY DESPITE THE BIOACTIVATION EVENT
      Amit S. Kalgutkar and Hang T. Nguyen
      Drug Metabolism and Disposition September 2004, 32 (9) 943-952;

  3. Niwa, Takuro

    1. IMPAIRED RENAL EXCRETION OF 6-HYDROXY-5,7-DIMETHYL-2-METHYLAMINO-4-(3-PYRIDYLMETHYL) BENZOTHIAZOLE (E3040) SULFATE IN BREAST CANCER RESISTANCE PROTEIN (BCRP1/ABCG2) KNOCKOUT MICE
      Naomi Mizuno, Michiko Suzuki, Hiroyuki Kusuhara, Hiroshi Suzuki, Kenji Takeuchi, Takuro Niwa, Johan W. Jonker and Yuichi Sugiyama
      Drug Metabolism and Disposition September 2004, 32 (9) 898-901;

O

  1. Öhman, K. P.

    1. PHARMACOKINETICS AND METABOLISM OF TESAGLITAZAR, A NOVEL DUAL-ACTING PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α/γ AGONIST, AFTER A SINGLE ORAL AND INTRAVENOUS DOSE IN HUMANS
      H. Ericsson, B. Hamrén, S. Bergstrand, M. Elebring, L. Fryklund, M. Heijer and K. P. Öhman
      Drug Metabolism and Disposition September 2004, 32 (9) 923-929;

  2. Ohno, Akiko

    1. SINGLE NUCLEOTIDE POLYMORPHISMS AND HAPLOTYPE FREQUENCIES OF UGT2B4 AND UGT2B7 IN A JAPANESE POPULATION
      Mayumi Saeki, Yoshiro Saito, Hideto Jinno, Toshiko Tanaka-Kagawa, Akiko Ohno, Shogo Ozawa, Kazuyuki Ueno, Shiro Kamakura, Naoyuki Kamatani, Kazuo Komamura, Masafumi Kitakaze and Jun-ichi Sawada
      Drug Metabolism and Disposition September 2004, 32 (9) 1048-1054;

  3. Osburg, Berit

    1. EFFECT OF POLY(ETHYLENE IMINE) MOLECULAR WEIGHT AND PEGYLATION ON ORGAN DISTRIBUTION AND PHARMACOKINETICS OF POLYPLEXES WITH OLIGODEOXYNUCLEOTIDES IN MICE
      Dagmar Fischer, Berit Osburg, Holger Petersen, Thomas Kissel and Ulrich Bickel
      Drug Metabolism and Disposition September 2004, 32 (9) 983-992;

  4. Ozawa, Shogo

    1. SINGLE NUCLEOTIDE POLYMORPHISMS AND HAPLOTYPE FREQUENCIES OF UGT2B4 AND UGT2B7 IN A JAPANESE POPULATION
      Mayumi Saeki, Yoshiro Saito, Hideto Jinno, Toshiko Tanaka-Kagawa, Akiko Ohno, Shogo Ozawa, Kazuyuki Ueno, Shiro Kamakura, Naoyuki Kamatani, Kazuo Komamura, Masafumi Kitakaze and Jun-ichi Sawada
      Drug Metabolism and Disposition September 2004, 32 (9) 1048-1054;

P

  1. Park, I-Na

    1. CERAMIDE, AN APOPTOTIC RHEOSTAT, INHIBITS CCAAT/ENHANCER BINDING PROTEIN-β AND NF-E2-RELATED FACTOR-2 ACTIVATION: THE ROLE IN GLUTATHIONE S-TRANSFERASE A2 GENE REPRESSION
      I-Na Park, Il Je Cho and Sang Geon Kim
      Drug Metabolism and Disposition September 2004, 32 (9) 893-897;

  2. Peiró, Ana Ma͢

    1. STEREOCHEMICAL ANALYSIS OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE AND ITS MAIN METABOLITES IN HUMAN SAMPLES INCLUDING THE CATECHOL-TYPE METABOLITE (3,4-DIHYDROXYMETHAMPHETAMINE)
      Nieves Pizarro, Magí Farré, Mitona Pujadas, Ana Ma͢ Peiró, Pere N Roset, Jesús Joglar and Rafael de la Torre
      Drug Metabolism and Disposition September 2004, 32 (9) 1001-1007;

  3. Petersen, Holger

    1. EFFECT OF POLY(ETHYLENE IMINE) MOLECULAR WEIGHT AND PEGYLATION ON ORGAN DISTRIBUTION AND PHARMACOKINETICS OF POLYPLEXES WITH OLIGODEOXYNUCLEOTIDES IN MICE
      Dagmar Fischer, Berit Osburg, Holger Petersen, Thomas Kissel and Ulrich Bickel
      Drug Metabolism and Disposition September 2004, 32 (9) 983-992;

  4. Pizarro, Nieves

    1. STEREOCHEMICAL ANALYSIS OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE AND ITS MAIN METABOLITES IN HUMAN SAMPLES INCLUDING THE CATECHOL-TYPE METABOLITE (3,4-DIHYDROXYMETHAMPHETAMINE)
      Nieves Pizarro, Magí Farré, Mitona Pujadas, Ana Ma͢ Peiró, Pere N Roset, Jesús Joglar and Rafael de la Torre
      Drug Metabolism and Disposition September 2004, 32 (9) 1001-1007;

  5. Pollack, Gary M.

    1. EFFECT OF PROTOTYPICAL INDUCING AGENTS ON P-GLYCOPROTEIN AND CYP3A EXPRESSION IN MOUSE TISSUES
      Christopher J. Matheny, Rabia Y. Ali, Xiaodong Yang and Gary M. Pollack
      Drug Metabolism and Disposition September 2004, 32 (9) 1008-1014;

  6. Pujadas, Mitona

    1. STEREOCHEMICAL ANALYSIS OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE AND ITS MAIN METABOLITES IN HUMAN SAMPLES INCLUDING THE CATECHOL-TYPE METABOLITE (3,4-DIHYDROXYMETHAMPHETAMINE)
      Nieves Pizarro, Magí Farré, Mitona Pujadas, Ana Ma͢ Peiró, Pere N Roset, Jesús Joglar and Rafael de la Torre
      Drug Metabolism and Disposition September 2004, 32 (9) 1001-1007;

R

  1. Ramírez, Jacqueline

    1. CYP2B6, CYP3A4, AND CYP2C19 ARE RESPONSIBLE FOR THE IN VITRO N-DEMETHYLATION OF MEPERIDINE IN HUMAN LIVER MICROSOMES
      Jacqueline Ramírez, Federico Innocenti, Erin G. Schuetz, David A. Flockhart, Mary V. Relling, Raymond Santucci and Mark J. Ratain
      Drug Metabolism and Disposition September 2004, 32 (9) 930-936;

  2. Ratain, Mark J.

    1. CYP2B6, CYP3A4, AND CYP2C19 ARE RESPONSIBLE FOR THE IN VITRO N-DEMETHYLATION OF MEPERIDINE IN HUMAN LIVER MICROSOMES
      Jacqueline Ramírez, Federico Innocenti, Erin G. Schuetz, David A. Flockhart, Mary V. Relling, Raymond Santucci and Mark J. Ratain
      Drug Metabolism and Disposition September 2004, 32 (9) 930-936;

  3. Reilly, Christopher A.

    1. BIOACTIVATION OF 1,1-DICHLOROETHYLENE TO ITS EPOXIDE BY CYP2E1 AND CYP2F ENZYMES
      Andrea C. Simmonds, Christopher A. Reilly, R. Michael Baldwin, Burhan I. Ghanayem, Diane L. Lanza, Garold S. Yost, Kathy S. Collins and Poh-Gek Forkert
      Drug Metabolism and Disposition September 2004, 32 (9) 1032-1039;

  4. Relling, Mary V.

    1. CYP2B6, CYP3A4, AND CYP2C19 ARE RESPONSIBLE FOR THE IN VITRO N-DEMETHYLATION OF MEPERIDINE IN HUMAN LIVER MICROSOMES
      Jacqueline Ramírez, Federico Innocenti, Erin G. Schuetz, David A. Flockhart, Mary V. Relling, Raymond Santucci and Mark J. Ratain
      Drug Metabolism and Disposition September 2004, 32 (9) 930-936;

  5. Rener, Gregory A.

    1. SELECTIVE REDUCTION OF N-OXIDES TO AMINES: APPLICATION TO DRUG METABOLISM
      Palaniappan Kulanthaivel, Robert J. Barbuch, Rita S. Davidson, Ping Yi, Gregory A. Rener, Edward L. Mattiuz, Chad E. Hadden, Lawrence A. Goodwin and William J. Ehlhardt
      Drug Metabolism and Disposition September 2004, 32 (9) 966-972;

  6. Roerig, David L.

    1. KINETIC CHARACTERIZATION OF P-GLYCOPROTEIN-MEDIATED EFFLUX OF RHODAMINE 6G IN THE INTACT RABBIT LUNG
      David L. Roerig, Said H. Audi and Susan B. Ahlf
      Drug Metabolism and Disposition September 2004, 32 (9) 953-958; DOI: https://doi.org/10.1124/dmd.104.000042

  7. Roset, Pere N

    1. STEREOCHEMICAL ANALYSIS OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE AND ITS MAIN METABOLITES IN HUMAN SAMPLES INCLUDING THE CATECHOL-TYPE METABOLITE (3,4-DIHYDROXYMETHAMPHETAMINE)
      Nieves Pizarro, Magí Farré, Mitona Pujadas, Ana Ma͢ Peiró, Pere N Roset, Jesús Joglar and Rafael de la Torre
      Drug Metabolism and Disposition September 2004, 32 (9) 1001-1007;

  8. Ruan, Ying

    1. GREEN TEA (CAMELLIA SINENSIS) EXTRACT DOES NOT ALTER CYTOCHROME P450 3A4 OR 2D6 ACTIVITY IN HEALTHY VOLUNTEERS
      Jennifer L. Donovan, Kenneth D. Chavin, C. Lindsay Devane, Robin M. Taylor, Jun-Sheng Wang, Ying Ruan and John S. Markowitz
      Drug Metabolism and Disposition September 2004, 32 (9) 906-908; DOI: https://doi.org/10.1124/dmd.104.000083

S

  1. Saeki, Mayumi

    1. SINGLE NUCLEOTIDE POLYMORPHISMS AND HAPLOTYPE FREQUENCIES OF UGT2B4 AND UGT2B7 IN A JAPANESE POPULATION
      Mayumi Saeki, Yoshiro Saito, Hideto Jinno, Toshiko Tanaka-Kagawa, Akiko Ohno, Shogo Ozawa, Kazuyuki Ueno, Shiro Kamakura, Naoyuki Kamatani, Kazuo Komamura, Masafumi Kitakaze and Jun-ichi Sawada
      Drug Metabolism and Disposition September 2004, 32 (9) 1048-1054;

  2. Saito, Konomu

    1. STRAIN DIFFERENCES IN DIAZEPAM METABOLISM AT ITS THREE METABOLIC SITES IN SPRAGUE-DAWLEY, BROWN NORWAY, DARK AGOUTI, AND WISTAR STRAIN RATS
      Konomu Saito, Noriaki Sakai, Hyung-Sub Kim, Mayumi Ishizuka, Akio Kazusaka and Shoichi Fujita
      Drug Metabolism and Disposition September 2004, 32 (9) 959-965;

  3. Saito, Yoshiro

    1. SINGLE NUCLEOTIDE POLYMORPHISMS AND HAPLOTYPE FREQUENCIES OF UGT2B4 AND UGT2B7 IN A JAPANESE POPULATION
      Mayumi Saeki, Yoshiro Saito, Hideto Jinno, Toshiko Tanaka-Kagawa, Akiko Ohno, Shogo Ozawa, Kazuyuki Ueno, Shiro Kamakura, Naoyuki Kamatani, Kazuo Komamura, Masafumi Kitakaze and Jun-ichi Sawada
      Drug Metabolism and Disposition September 2004, 32 (9) 1048-1054;

  4. Sakai, Noriaki

    1. STRAIN DIFFERENCES IN DIAZEPAM METABOLISM AT ITS THREE METABOLIC SITES IN SPRAGUE-DAWLEY, BROWN NORWAY, DARK AGOUTI, AND WISTAR STRAIN RATS
      Konomu Saito, Noriaki Sakai, Hyung-Sub Kim, Mayumi Ishizuka, Akio Kazusaka and Shoichi Fujita
      Drug Metabolism and Disposition September 2004, 32 (9) 959-965;

  5. Santucci, Raymond

    1. CYP2B6, CYP3A4, AND CYP2C19 ARE RESPONSIBLE FOR THE IN VITRO N-DEMETHYLATION OF MEPERIDINE IN HUMAN LIVER MICROSOMES
      Jacqueline Ramírez, Federico Innocenti, Erin G. Schuetz, David A. Flockhart, Mary V. Relling, Raymond Santucci and Mark J. Ratain
      Drug Metabolism and Disposition September 2004, 32 (9) 930-936;

  6. Satoh, Hiroya

    1. IN VITRO METABOLISM OF MK-0767 [(±)-5-[(2,4-DIOXOTHIAZOLIDIN-5-YL)METHYL]-2-METHOXY-N-[[(4-TRIFLUOROMETHYL) PHENYL]METHYL]BENZAMIDE], A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α/γ AGONIST. I. ROLE OF CYTOCHROME P450, METHYLTRANSFERASES, FLAVIN MONOOXYGENASES, AND ESTERASES
      Bindhu V. Karanam, Cornelis E.C.A. Hop, David Q. Liu, Mike Wallace, Dennis Dean, Hiroya Satoh, Masakatsu Komuro, Katsuya Awano and Stella H. Vincent
      Drug Metabolism and Disposition September 2004, 32 (9) 1015-1022; DOI: https://doi.org/10.1124/dmd.104.000034

  7. Sawada, Jun-ichi

    1. SINGLE NUCLEOTIDE POLYMORPHISMS AND HAPLOTYPE FREQUENCIES OF UGT2B4 AND UGT2B7 IN A JAPANESE POPULATION
      Mayumi Saeki, Yoshiro Saito, Hideto Jinno, Toshiko Tanaka-Kagawa, Akiko Ohno, Shogo Ozawa, Kazuyuki Ueno, Shiro Kamakura, Naoyuki Kamatani, Kazuo Komamura, Masafumi Kitakaze and Jun-ichi Sawada
      Drug Metabolism and Disposition September 2004, 32 (9) 1048-1054;

  8. Schuetz, Erin G.

    1. CYP2B6, CYP3A4, AND CYP2C19 ARE RESPONSIBLE FOR THE IN VITRO N-DEMETHYLATION OF MEPERIDINE IN HUMAN LIVER MICROSOMES
      Jacqueline Ramírez, Federico Innocenti, Erin G. Schuetz, David A. Flockhart, Mary V. Relling, Raymond Santucci and Mark J. Ratain
      Drug Metabolism and Disposition September 2004, 32 (9) 930-936;

  9. Shen, Zhongzhou

    1. DIFFERENCES IN THE PHARMACOKINETICS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONISTS IN GENETICALLY OBESE ZUCKER AND SPRAGUE-DAWLEY RATS: IMPLICATIONS OF DECREASED GLUCURONIDATION IN OBESE ZUCKER RATS
      Mi-Sook Kim, Sui Wang, Zhongzhou Shen, Christopher J. Kochansky, John R. Strauss, Ronald B. Franklin and Stella H. Vincent
      Drug Metabolism and Disposition September 2004, 32 (9) 909-914;

  10. Sidler, Rick R.

    1. IN VITRO METABOLISM OF MK-0767 [(±)-5-[(2,4-DIOXOTHIAZOLIDIN-5-YL)METHYL]-2-METHOXY-N-[[(4-TRIFLUOROMETHYL)-PHENYL] METHYL]BENZAMIDE], A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α/γ AGONIST. II. IDENTIFICATION OF METABOLITES BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY
      David Q. Liu, Bindhu V. Karanam, George A. Doss, Rick R. Sidler, Stella H. Vincent and Cornelis E.C.A. Hop
      Drug Metabolism and Disposition September 2004, 32 (9) 1023-1031; DOI: https://doi.org/10.1124/dmd.104.000059

  11. Simmonds, Andrea C.

    1. BIOACTIVATION OF 1,1-DICHLOROETHYLENE TO ITS EPOXIDE BY CYP2E1 AND CYP2F ENZYMES
      Andrea C. Simmonds, Christopher A. Reilly, R. Michael Baldwin, Burhan I. Ghanayem, Diane L. Lanza, Garold S. Yost, Kathy S. Collins and Poh-Gek Forkert
      Drug Metabolism and Disposition September 2004, 32 (9) 1032-1039;

  12. Smith, Philip C.

    1. ALTERED PHARMACOKINETICS OF OMEPRAZOLE IN CYSTIC FIBROSIS KNOCKOUT MICE RELATIVE TO WILD-TYPE MICE
      Melanie N. Tallman, Shazia Y. Ali and Philip C. Smith
      Drug Metabolism and Disposition September 2004, 32 (9) 902-905;

  13. Strauss, John R.

    1. DIFFERENCES IN THE PHARMACOKINETICS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONISTS IN GENETICALLY OBESE ZUCKER AND SPRAGUE-DAWLEY RATS: IMPLICATIONS OF DECREASED GLUCURONIDATION IN OBESE ZUCKER RATS
      Mi-Sook Kim, Sui Wang, Zhongzhou Shen, Christopher J. Kochansky, John R. Strauss, Ronald B. Franklin and Stella H. Vincent
      Drug Metabolism and Disposition September 2004, 32 (9) 909-914;

  14. Sugiyama, Yuichi

    1. CARRIER-MEDIATED UPTAKE OF H2-RECEPTOR ANTAGONISTS BY THE RAT CHOROID PLEXUS: INVOLVEMENT OF RAT ORGANIC ANION TRANSPORTER 3
      Yoshinori Nagata, Hiroyuki Kusuhara, Shuichi Hirono, Hitoshi Endou and Yuichi Sugiyama
      Drug Metabolism and Disposition September 2004, 32 (9) 1040-1047;
    2. IMPAIRED RENAL EXCRETION OF 6-HYDROXY-5,7-DIMETHYL-2-METHYLAMINO-4-(3-PYRIDYLMETHYL) BENZOTHIAZOLE (E3040) SULFATE IN BREAST CANCER RESISTANCE PROTEIN (BCRP1/ABCG2) KNOCKOUT MICE
      Naomi Mizuno, Michiko Suzuki, Hiroyuki Kusuhara, Hiroshi Suzuki, Kenji Takeuchi, Takuro Niwa, Johan W. Jonker and Yuichi Sugiyama
      Drug Metabolism and Disposition September 2004, 32 (9) 898-901;

  15. Suzuki, Hiroshi

    1. IMPAIRED RENAL EXCRETION OF 6-HYDROXY-5,7-DIMETHYL-2-METHYLAMINO-4-(3-PYRIDYLMETHYL) BENZOTHIAZOLE (E3040) SULFATE IN BREAST CANCER RESISTANCE PROTEIN (BCRP1/ABCG2) KNOCKOUT MICE
      Naomi Mizuno, Michiko Suzuki, Hiroyuki Kusuhara, Hiroshi Suzuki, Kenji Takeuchi, Takuro Niwa, Johan W. Jonker and Yuichi Sugiyama
      Drug Metabolism and Disposition September 2004, 32 (9) 898-901;

  16. Suzuki, Michiko

    1. IMPAIRED RENAL EXCRETION OF 6-HYDROXY-5,7-DIMETHYL-2-METHYLAMINO-4-(3-PYRIDYLMETHYL) BENZOTHIAZOLE (E3040) SULFATE IN BREAST CANCER RESISTANCE PROTEIN (BCRP1/ABCG2) KNOCKOUT MICE
      Naomi Mizuno, Michiko Suzuki, Hiroyuki Kusuhara, Hiroshi Suzuki, Kenji Takeuchi, Takuro Niwa, Johan W. Jonker and Yuichi Sugiyama
      Drug Metabolism and Disposition September 2004, 32 (9) 898-901;

T

  1. Takeuchi, Kenji

    1. IMPAIRED RENAL EXCRETION OF 6-HYDROXY-5,7-DIMETHYL-2-METHYLAMINO-4-(3-PYRIDYLMETHYL) BENZOTHIAZOLE (E3040) SULFATE IN BREAST CANCER RESISTANCE PROTEIN (BCRP1/ABCG2) KNOCKOUT MICE
      Naomi Mizuno, Michiko Suzuki, Hiroyuki Kusuhara, Hiroshi Suzuki, Kenji Takeuchi, Takuro Niwa, Johan W. Jonker and Yuichi Sugiyama
      Drug Metabolism and Disposition September 2004, 32 (9) 898-901;

  2. Tallman, Melanie N.

    1. ALTERED PHARMACOKINETICS OF OMEPRAZOLE IN CYSTIC FIBROSIS KNOCKOUT MICE RELATIVE TO WILD-TYPE MICE
      Melanie N. Tallman, Shazia Y. Ali and Philip C. Smith
      Drug Metabolism and Disposition September 2004, 32 (9) 902-905;

  3. Tanaka-Kagawa, Toshiko

    1. SINGLE NUCLEOTIDE POLYMORPHISMS AND HAPLOTYPE FREQUENCIES OF UGT2B4 AND UGT2B7 IN A JAPANESE POPULATION
      Mayumi Saeki, Yoshiro Saito, Hideto Jinno, Toshiko Tanaka-Kagawa, Akiko Ohno, Shogo Ozawa, Kazuyuki Ueno, Shiro Kamakura, Naoyuki Kamatani, Kazuo Komamura, Masafumi Kitakaze and Jun-ichi Sawada
      Drug Metabolism and Disposition September 2004, 32 (9) 1048-1054;

  4. Taylor, Robin M.

    1. GREEN TEA (CAMELLIA SINENSIS) EXTRACT DOES NOT ALTER CYTOCHROME P450 3A4 OR 2D6 ACTIVITY IN HEALTHY VOLUNTEERS
      Jennifer L. Donovan, Kenneth D. Chavin, C. Lindsay Devane, Robin M. Taylor, Jun-Sheng Wang, Ying Ruan and John S. Markowitz
      Drug Metabolism and Disposition September 2004, 32 (9) 906-908; DOI: https://doi.org/10.1124/dmd.104.000083

U

  1. Ueno, Kazuyuki

    1. SINGLE NUCLEOTIDE POLYMORPHISMS AND HAPLOTYPE FREQUENCIES OF UGT2B4 AND UGT2B7 IN A JAPANESE POPULATION
      Mayumi Saeki, Yoshiro Saito, Hideto Jinno, Toshiko Tanaka-Kagawa, Akiko Ohno, Shogo Ozawa, Kazuyuki Ueno, Shiro Kamakura, Naoyuki Kamatani, Kazuo Komamura, Masafumi Kitakaze and Jun-ichi Sawada
      Drug Metabolism and Disposition September 2004, 32 (9) 1048-1054;

V

  1. Vincent, Stella H.

    1. IN VITRO METABOLISM OF MK-0767 [(±)-5-[(2,4-DIOXOTHIAZOLIDIN-5-YL)METHYL]-2-METHOXY-N-[[(4-TRIFLUOROMETHYL) PHENYL]METHYL]BENZAMIDE], A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α/γ AGONIST. I. ROLE OF CYTOCHROME P450, METHYLTRANSFERASES, FLAVIN MONOOXYGENASES, AND ESTERASES
      Bindhu V. Karanam, Cornelis E.C.A. Hop, David Q. Liu, Mike Wallace, Dennis Dean, Hiroya Satoh, Masakatsu Komuro, Katsuya Awano and Stella H. Vincent
      Drug Metabolism and Disposition September 2004, 32 (9) 1015-1022; DOI: https://doi.org/10.1124/dmd.104.000034
    2. IN VITRO METABOLISM OF MK-0767 [(±)-5-[(2,4-DIOXOTHIAZOLIDIN-5-YL)METHYL]-2-METHOXY-N-[[(4-TRIFLUOROMETHYL)-PHENYL] METHYL]BENZAMIDE], A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α/γ AGONIST. II. IDENTIFICATION OF METABOLITES BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY
      David Q. Liu, Bindhu V. Karanam, George A. Doss, Rick R. Sidler, Stella H. Vincent and Cornelis E.C.A. Hop
      Drug Metabolism and Disposition September 2004, 32 (9) 1023-1031; DOI: https://doi.org/10.1124/dmd.104.000059
    3. DIFFERENCES IN THE PHARMACOKINETICS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONISTS IN GENETICALLY OBESE ZUCKER AND SPRAGUE-DAWLEY RATS: IMPLICATIONS OF DECREASED GLUCURONIDATION IN OBESE ZUCKER RATS
      Mi-Sook Kim, Sui Wang, Zhongzhou Shen, Christopher J. Kochansky, John R. Strauss, Ronald B. Franklin and Stella H. Vincent
      Drug Metabolism and Disposition September 2004, 32 (9) 909-914;

W

  1. Wallace, Mike

    1. IN VITRO METABOLISM OF MK-0767 [(±)-5-[(2,4-DIOXOTHIAZOLIDIN-5-YL)METHYL]-2-METHOXY-N-[[(4-TRIFLUOROMETHYL) PHENYL]METHYL]BENZAMIDE], A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α/γ AGONIST. I. ROLE OF CYTOCHROME P450, METHYLTRANSFERASES, FLAVIN MONOOXYGENASES, AND ESTERASES
      Bindhu V. Karanam, Cornelis E.C.A. Hop, David Q. Liu, Mike Wallace, Dennis Dean, Hiroya Satoh, Masakatsu Komuro, Katsuya Awano and Stella H. Vincent
      Drug Metabolism and Disposition September 2004, 32 (9) 1015-1022; DOI: https://doi.org/10.1124/dmd.104.000034

  2. Wang, Jun-Sheng

    1. GREEN TEA (CAMELLIA SINENSIS) EXTRACT DOES NOT ALTER CYTOCHROME P450 3A4 OR 2D6 ACTIVITY IN HEALTHY VOLUNTEERS
      Jennifer L. Donovan, Kenneth D. Chavin, C. Lindsay Devane, Robin M. Taylor, Jun-Sheng Wang, Ying Ruan and John S. Markowitz
      Drug Metabolism and Disposition September 2004, 32 (9) 906-908; DOI: https://doi.org/10.1124/dmd.104.000083

  3. Wang, Sui

    1. DIFFERENCES IN THE PHARMACOKINETICS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONISTS IN GENETICALLY OBESE ZUCKER AND SPRAGUE-DAWLEY RATS: IMPLICATIONS OF DECREASED GLUCURONIDATION IN OBESE ZUCKER RATS
      Mi-Sook Kim, Sui Wang, Zhongzhou Shen, Christopher J. Kochansky, John R. Strauss, Ronald B. Franklin and Stella H. Vincent
      Drug Metabolism and Disposition September 2004, 32 (9) 909-914;

  4. White, Ronald E.

    1. EVALUATION OF A NOVEL IN VITRO CACO-2 HEPATOCYTE HYBRID SYSTEM FOR PREDICTING IN VIVO ORAL BIOAVAILABILITY
      Yau Yi Lau, Yung-Hsiang Chen, Tong-tong Liu, Cheng Li, Xiaoming Cui, Ronald E. White and K.-C. Cheng
      Drug Metabolism and Disposition September 2004, 32 (9) 937-942;

Y

  1. Yang, Xiaodong

    1. EFFECT OF PROTOTYPICAL INDUCING AGENTS ON P-GLYCOPROTEIN AND CYP3A EXPRESSION IN MOUSE TISSUES
      Christopher J. Matheny, Rabia Y. Ali, Xiaodong Yang and Gary M. Pollack
      Drug Metabolism and Disposition September 2004, 32 (9) 1008-1014;

  2. Yi, Ping

    1. SELECTIVE REDUCTION OF N-OXIDES TO AMINES: APPLICATION TO DRUG METABOLISM
      Palaniappan Kulanthaivel, Robert J. Barbuch, Rita S. Davidson, Ping Yi, Gregory A. Rener, Edward L. Mattiuz, Chad E. Hadden, Lawrence A. Goodwin and William J. Ehlhardt
      Drug Metabolism and Disposition September 2004, 32 (9) 966-972;

  3. Yost, Garold S.

    1. BIOACTIVATION OF 1,1-DICHLOROETHYLENE TO ITS EPOXIDE BY CYP2E1 AND CYP2F ENZYMES
      Andrea C. Simmonds, Christopher A. Reilly, R. Michael Baldwin, Burhan I. Ghanayem, Diane L. Lanza, Garold S. Yost, Kathy S. Collins and Poh-Gek Forkert
      Drug Metabolism and Disposition September 2004, 32 (9) 1032-1039;

Z

  1. Zheng, Naiyu

    1. KINETICS AND REGULATION OF CYTOCHROME P450-MEDIATED ETOPOSIDE METABOLISM
      Xiaoliang Zhuo, Naiyu Zheng, Carolyn A. Felix and Ian A. Blair
      Drug Metabolism and Disposition September 2004, 32 (9) 993-1000;

  2. Zhuo, Xiaoliang

    1. KINETICS AND REGULATION OF CYTOCHROME P450-MEDIATED ETOPOSIDE METABOLISM
      Xiaoliang Zhuo, Naiyu Zheng, Carolyn A. Felix and Ian A. Blair
      Drug Metabolism and Disposition September 2004, 32 (9) 993-1000;
Back to top

In this issue

Advertisement